Dr. James McNess
Surgical Audit
Audit Interval: From 24/06/14 to 02/07/14
CI 1.1 | Gynaecological surgery for benign disease ? unplanned intra- or post-operative blood transfusion
| Number of patients receiving an unplanned intra-operative or post-operative blood transfusion during their hospital admission for any type of gynaecological surgery for benign disease. (16)
| Number of patients undergoing gynaecological surgery for benign disease (19)
16/19 = 84.21%
CI 2.1 | Gynaecological surgery - injury to a major viscus with repair
| Number of patients suffering injury to a major viscus with repair, during a gynaecological operative procedure or subsequently up to 2 weeks post-operatively. (2)
| Number of patients undergoing gynaecological surgery for benign disease. (19)
2/19 = 10.53%
CI 3.1 | Ectopic pregnancy managed laparoscopically
| Number of patients having laparoscopic management of an ectopic pregnancy. (8)
| Number of patients presenting with an ectopic pregnancy who are managed surgically. (14)
8/14 = 57.14%
CI 4.1 | Thromboprophylaxis for major gynaecological surgery
| Number of patients undergoing major gynaecological surgery who receive thromboprophylaxis according to hospital guidelines. (1)
| Number of patients undergoing major gynaecological surgery. (19)
1/19 = 5.26%
CI 4.2 | Re-admission for venous thromboembolism within 28 days
| Number of patients who develop or are re-admitted with venous thromboembolism (VTE) within 28 days of major gynaecological surgery. (6)
| Number of patients undergoing major gynaecological surgery. (19)
6/19 = 31.58%
CI 5.1 | Use of mesh repair for pelvic organ prolapse
| Number of patients having mesh repair. (4)
| Number of patients having a repair for pelvic organ prolapse. (17)
4/17 = 23.53%
CI 6.1 | Surgical intervention for menorrhagia
| Number of patients undergoing a hysterectomy for menorrhagia. (6)
| Number of patients undergoing gynaecological surgery to treat menorrhagia. (18)
6/18 = 33.33%